Cuidados

Oncology News

Gene expression profiling has identified fibronectin 1 and chemokine ligand 9 as candidate biomarkers for breast cancer screening, French researchers report.

Results of a US feasibility study show that robot-assisted radical prostatectomy can be undertaken as an outpatient procedure with no adverse consequences for patient satisfaction or safety.

Postoperative breast changes following reduction mammoplasty do not hinder analysis of the screening mammogram, Australian researchers report.

Every eighth man undergoing repeated prostate-specific antigen screening will have at least one false-positive result, show findings from the Finnish component of the European Randomized Study of Screening for Prostate Cancer.

The loss of a single nucleotide polymorphism located in the gene encoding the disabled homolog 2 interacting protein in prostate cancer cells may be responsible for cancer progression to other organs, show study findings.

A significantly larger proportion of prostate cancer patients treated with definitive radiotherapy report chronic fatigue 1 year after treatment than their radical prostatectomy-treated counterparts, report researchers.

Prostate cancer patients treated with robotic-assisted laparoscopic radical prostatectomy experience low rates of peri-operative complications, even when the procedure is carried out by surgeons new to the technique, report researchers.

Women with small sized invasive screen-detected breast cancer have the same life expectancy as the general population, a long-term follow-up study in The Netherlands reveals.

Treatment with the aromatase inhibitior letrozole plus the anti-vascular endothelial growth factor antibody bevacizumab is feasible in postmenopausal patients with hormone receptor-positive metastatic breast cancer, US research shows.

US research findings confirm the involvement of ELAC2, MSR1, and RNASEL genes in the risk for development of prostate cancer, and show that the risk varies according to ethnicity.